Anas Jaber offers her racket for sale to combat the Covid-19 epidemic in Tunisia
Tunisian tennis player Anas Jaber announced Monday that she will offer her racket for sale to help her country’s hospitals, which are experiencing overcrowding due to the spread of the “Covid-19” virus.
Jaber, who wrote an Arab history by reaching the English quarter-finals of Wimbledon, the third Grand Slam, said in a video clip that she posted on her pages on social media that “for a noble purpose … like any Tunisian, I cannot watch my country go through difficult circumstances.”
Jaber (23 globally) indicated that the price she will collect will be allocated to acquiring the necessary medicines and medical equipment. The player will also add an amount to the price at which the racket will be sold.
The racket was put up for sale at midday on Monday at a public auction, starting at 2,000 dinars (about 600 euros) and reaching 7,270 dinars (about 2,200 euros) after only two hours, according to the fundraiser, Hajar Idris.
Jaber displayed the racket with which she beat American Venus Williams, the five-time Wimbledon champion, Spain’s Garbine Mugurosa and Belarusian Arina Sabalenka, the Roland Garros champion in 2020.
The racket was put up for auction for 48 hours.
The goal is to raise funds to buy a recovery bed for a hospital in the regions, the price of which reaches 30,000 dinars (about 10,000 euros), according to Idris.
During this period, Tunisian government hospitals are facing unprecedented overcrowding due to the high number of patients with Covid-19, and it is no longer possible to respond to the treatment of all patients due to a lack of equipment and medical staff.
Tunisia, which records the “highest” number of deaths in the region, according to the World Health Organization, has recorded more than 16,000 deaths since March 2020 in a country of about 12 million people.
The country is facing difficulties in obtaining the vaccine, as its stock of the Pfizer vaccine has run out, and it has also been vaccinated with 93% of the AstraZeneca vaccines it owns.